423 related articles for article (PubMed ID: 27497924)
21. Olfactory involvement in aging and Alzheimer's disease: an autopsy study.
Attems J; Lintner F; Jellinger KA
J Alzheimers Dis; 2005 Apr; 7(2):149-57; discussion 173-80. PubMed ID: 15851853
[TBL] [Abstract][Full Text] [Related]
22. From tangles to tau protein.
Iqbal K; Novak M
Bratisl Lek Listy; 2006; 107(9-10):341-2. PubMed ID: 17262984
[TBL] [Abstract][Full Text] [Related]
23. Characterizing tau deposition in chronic traumatic encephalopathy (CTE): utility of the McKee CTE staging scheme.
Alosco ML; Cherry JD; Huber BR; Tripodis Y; Baucom Z; Kowall NW; Saltiel N; Goldstein LE; Katz DI; Dwyer B; Daneshvar DH; Palmisano JN; Martin B; Cantu RC; Stern RA; Alvarez VE; Mez J; Stein TD; McKee AC
Acta Neuropathol; 2020 Oct; 140(4):495-512. PubMed ID: 32778942
[TBL] [Abstract][Full Text] [Related]
24. Pathogenic tau modifications occur in axons before the somatodendritic compartment in mossy fiber and Schaffer collateral pathways.
Christensen KR; Beach TG; Serrano GE; Kanaan NM
Acta Neuropathol Commun; 2019 Feb; 7(1):29. PubMed ID: 30819250
[TBL] [Abstract][Full Text] [Related]
25. Tau pathology in the medial temporal lobe of athletes with chronic traumatic encephalopathy: a chronic effects of neurotrauma consortium study.
Kelley CM; Perez SE; Mufson EJ
Acta Neuropathol Commun; 2019 Dec; 7(1):207. PubMed ID: 31831066
[TBL] [Abstract][Full Text] [Related]
26. Tau immunophenotypes in chronic traumatic encephalopathy recapitulate those of ageing and Alzheimer's disease.
Arena JD; Smith DH; Lee EB; Gibbons GS; Irwin DJ; Robinson JL; Lee VM; Trojanowski JQ; Stewart W; Johnson VE
Brain; 2020 May; 143(5):1572-1587. PubMed ID: 32390044
[TBL] [Abstract][Full Text] [Related]
27. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies.
Irwin DJ; Cohen TJ; Grossman M; Arnold SE; Xie SX; Lee VM; Trojanowski JQ
Brain; 2012 Mar; 135(Pt 3):807-18. PubMed ID: 22366796
[TBL] [Abstract][Full Text] [Related]
28. Decline in word-finding: The objective cognitive finding most relevant to patients after mesial temporal lobe epilepsy surgery.
Pauli C; de Oliveira Thais MER; Guarnieri R; Schwarzbold ML; Diaz AP; Ben J; Linhares MN; Markowitsch HJ; Wolf P; Wiebe S; Lin K; Walz R
Epilepsy Behav; 2017 Oct; 75():218-224. PubMed ID: 28867574
[TBL] [Abstract][Full Text] [Related]
29. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
[TBL] [Abstract][Full Text] [Related]
30. Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease.
Mitchell TW; Mufson EJ; Schneider JA; Cochran EJ; Nissanov J; Han LY; Bienias JL; Lee VM; Trojanowski JQ; Bennett DA; Arnold SE
Ann Neurol; 2002 Feb; 51(2):182-9. PubMed ID: 11835374
[TBL] [Abstract][Full Text] [Related]
31. Regional distribution and maturation of tau pathology among phenotypic variants of Alzheimer's disease.
Arezoumandan S; Xie SX; Cousins KAQ; Mechanic-Hamilton DJ; Peterson CS; Huang CY; Ohm DT; Ittyerah R; McMillan CT; Wolk DA; Yushkevich P; Trojanowski JQ; Lee EB; Grossman M; Phillips JS; Irwin DJ
Acta Neuropathol; 2022 Dec; 144(6):1103-1116. PubMed ID: 35871112
[TBL] [Abstract][Full Text] [Related]
32. [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging.
Marquié M; Siao Tick Chong M; Antón-Fernández A; Verwer EE; Sáez-Calveras N; Meltzer AC; Ramanan P; Amaral AC; Gonzalez J; Normandin MD; Frosch MP; Gómez-Isla T
Acta Neuropathol; 2017 Oct; 134(4):619-628. PubMed ID: 28612291
[TBL] [Abstract][Full Text] [Related]
33. Aluminum and Neurofibrillary Tangle Co-Localization in Familial Alzheimer's Disease and Related Neurological Disorders.
Mold MJ; O'Farrell A; Morris B; Exley C
J Alzheimers Dis; 2020; 78(1):139-149. PubMed ID: 32925074
[TBL] [Abstract][Full Text] [Related]
34. Hyperphosphorylated Tau in Mesial Temporal Lobe Epilepsy: a Neuropathological and Cognitive Study.
Toscano ECB; Vieira ÉLM; Grinberg LT; Rocha NP; Brant JAS; Paradela RS; Giannetti AV; Suemoto CK; Leite REP; Nitrini R; Rachid MA; Teixeira AL
Mol Neurobiol; 2023 Apr; 60(4):2174-2185. PubMed ID: 36622561
[TBL] [Abstract][Full Text] [Related]
35. Tau Phosphorylation in a Mouse Model of Temporal Lobe Epilepsy.
Alves M; Kenny A; de Leo G; Beamer EH; Engel T
Front Aging Neurosci; 2019; 11():308. PubMed ID: 31780921
[TBL] [Abstract][Full Text] [Related]
36. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies.
Xia Y; Prokop S; Gorion KM; Kim JD; Sorrentino ZA; Bell BM; Manaois AN; Chakrabarty P; Davies P; Giasson BI
Acta Neuropathol Commun; 2020 Jun; 8(1):88. PubMed ID: 32571418
[TBL] [Abstract][Full Text] [Related]
37. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
Attems J; Jellinger KA
Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
[TBL] [Abstract][Full Text] [Related]
38. Is phosphorylated tau unique to chronic traumatic encephalopathy? Phosphorylated tau in epileptic brain and chronic traumatic encephalopathy.
Puvenna V; Engeler M; Banjara M; Brennan C; Schreiber P; Dadas A; Bahrami A; Solanki J; Bandyopadhyay A; Morris JK; Bernick C; Ghosh C; Rapp E; Bazarian JJ; Janigro D
Brain Res; 2016 Jan; 1630():225-40. PubMed ID: 26556772
[TBL] [Abstract][Full Text] [Related]
39. Seizures are a druggable mechanistic link between TBI and subsequent tauopathy.
Alyenbaawi H; Kanyo R; Locskai LF; Kamali-Jamil R; DuVal MG; Bai Q; Wille H; Burton EA; Allison WT
Elife; 2021 Feb; 10():. PubMed ID: 33527898
[TBL] [Abstract][Full Text] [Related]
40. Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms.
Hwang K; Vaknalli RN; Addo-Osafo K; Vicente M; Vossel K
Front Aging Neurosci; 2022; 14():903973. PubMed ID: 35923547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
